Acquisition-hungry Medtronic buys leading stent maker
This article was originally published in Clinica
Executive Summary
Medtronic will significantly boost its interventional cardiology business through the acquisition of leading stent manufacturer Arterial Vascular Engineering (AVE) in a $3.7 billion transaction. The deal is the latest in a string of acquisitions by Medtronic this year, which are expected to almost double the company's turnover to $5 billion in the next fiscal year.
You may also be interested in...
MoCRA Stakeholders Reminded Registration Enforcement Begins 1 July: ‘Do Not Delay!’
The Independent Beauty Association urged stakeholders at its Cosmetic Convergence Symposium to take action to ensure they are meeting requirements of the Modernization of Cosmetics Regulation Act come 1 July, when FDA’s enforcement of the facility and product registration deadline begins. Presenters offered tips from companies that have already completed the process.
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.